Jasper Therapeutics, Inc. (JSPR) Ownership

$5.13

$0.02 (-0.39%)
Last update: 04:00 PM EST
Day's range
$4.76
Day's range
$5.59

Jasper Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SOLEUS CAPITAL MANAGEMENT, L.P. 05/15/2025 1.49 M $6.43 M   0.00% 10.25%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 05/15/2025 1.43 M $6.17 M   0.00% 9.83%
CARLYLE GROUP INC. 05/09/2025 1.07 M $4.58 M   0.00% 7.31%
BLACKROCK, INC. 05/02/2025 787.61 K $3.39 M   -2.53% 5.40%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 05/14/2025 702.76 K $3.02 M   755.30% 4.82%
VANGUARD GROUP INC 05/09/2025 679.45 K $2.92 M   -4.23% 4.66%
MORGAN STANLEY 05/15/2025 653.98 K $2.81 M   8.13% 4.48%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 05/15/2025 575.00 K $2.47 M   -11.54% 3.94%
FRANKLIN RESOURCES INC 05/13/2025 534.71 K $2.30 M   -7.75% 3.67%
UBS GROUP AG 05/13/2025 534.64 K $2.30 M   225.37% 3.67%
KINGDON CAPITAL MANAGEMENT, L.L.C. 05/15/2025 490.00 K $2.11 M   9.62% 3.36%
CITADEL ADVISORS LLC 05/15/2025 375.17 K $1.61 M   -11.44% 2.57%
BANK OF AMERICA CORP /DE/ 05/15/2025 360.69 K $1.55 M   25.59% 2.47%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 263.68 K $1.13 M   2.33% 1.81%
GOLDMAN SACHS GROUP INC 05/16/2025 233.76 K $1.01 M   11.15% 1.60%
STATE STREET CORP 05/15/2025 227.88 K $979.87 K   -1.06% 1.56%
DEUTSCHE BANK AG\ 05/09/2025 169.35 K $728.21 K   -0.79% 1.16%
LION POINT CAPITAL, LP 05/15/2025 146.50 K $629.95 K   357.81% 1.00%
SPHERA FUNDS MANAGEMENT LTD. 05/15/2025 122.02 K $524.67 K   -10.10% 0.84%
NORTHERN TRUST CORP 05/13/2025 103.09 K $443.29 K   -1.22% 0.71%
05/12/2025 102.27 K $439.75 K   100.00% 0.70%
BANK OF MONTREAL /CAN/ 05/13/2025 71.74 K $308.48 K   100.00% 0.49%
DIMENSIONAL FUND ADVISORS LP 05/13/2025 44.66 K $192.04 K   18.45% 0.31%
VERITION FUND MANAGEMENT LLC 05/15/2025 33.22 K $142.84 K   120.72% 0.23%
MARINER, LLC 05/15/2025 31.19 K $134.12 K   -15.23% 0.21%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 26.65 K $114.59 K   -17.59% 0.18%
MILLENNIUM MANAGEMENT LLC 05/15/2025 25.94 K $111.54 K   100.00% 0.18%
IKARIAN CAPITAL, LLC 05/15/2025 25.11 K $107.96 K   -54.44% 0.17%
BANK OF NEW YORK MELLON CORP 04/29/2025 25.03 K $107.62 K   -0.20% 0.17%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 23.70 K $101.91 K   -46.50% 0.16%
CITADEL ADVISORS LLC 05/15/2025 22.20 K $95.46 K   73.44% 0.15%
SOWELL FINANCIAL SERVICES LLC 04/17/2025 20.83 K $89.55 K   -25.74% 0.14%
SEI INVESTMENTS CO 05/14/2025 18.85 K $81.06 K   100.00% 0.13%
BARCLAYS PLC 05/15/2025 17.96 K $77.00 K   -2.04% 0.12%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 16.09 K $69.19 K   -29.47% 0.11%
RHUMBLINE ADVISERS 05/29/2025 15.59 K $67.05 K   5.64% 0.11%
FMR LLC 05/12/2025 15.01 K $64.56 K   -96.14% 0.10%
BNP PARIBAS ARBITRAGE, SNC 05/14/2025 14.81 K $63.67 K   412.74% 0.10%
ACADIAN ASSET MANAGEMENT LLC 05/21/2025 10.71 K $46.00 K   100.00% 0.07%
STATE OF WISCONSIN INVESTMENT BOARD 05/15/2025 10.57 K $45.46 K   -22.97% 0.07%
CITIGROUP INC 05/12/2025 8.06 K $34.65 K   -11.07% 0.06%
CITADEL ADVISORS LLC 05/15/2025 8.00 K $34.40 K   433.33% 0.05%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 05/15/2025 6.83 K $29.36 K   4.79% 0.05%
WELLS FARGO & COMPANY/MN 05/13/2025 6.11 K $26.27 K   -17.60% 0.04%
COREBRIDGE FINANCIAL, INC. 05/14/2025 5.55 K $23.85 K   -1.46% 0.04%
JPMORGAN CHASE & CO 05/12/2025 5.54 K $23.83 K   7.28% 0.04%
NEW YORK STATE COMMON RETIREMENT FUND 05/01/2025 4.60 K $20.00 K   0.00% 0.03%
CREWE ADVISORS LLC 04/23/2025 3.10 K $13.33 K   100.00% 0.02%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2025 2.49 K $10.70 K   60.00% 0.02%
05/09/2025 2.28 K $9.79 K   0.00% 0.02%

Jasper Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 91 institutional investors and hedge funds held shares of Jasper Therapeutics, Inc.. The most heavily invested institutionals were:

Soleus Capital Management, L.P.: 1.49 M

Velan Capital Investment Management LP: 1.43 M

Carlyle Group Inc.: 1.07 M

BlackRock, Inc.: 787,605

T. Rowe Price Investment Management, Inc.: 702,757

VANGUARD GROUP INC: 679,452

79.08% of Jasper Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 18.45 M shares in the last 24 months. This purchase volume represents approximately $94.49 M in transactions.